Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Aryl ureas for cytokine- and MMP-mediated conditions disclosed by Bayer

July 30, 1999

Cytokine production inhibitors from SB particularly useful for inflammation, osteoporosis

July 27, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

Fungal metabolites useful as IL-1/TNF production inhibitors

July 23, 1999

P2X7 receptor antagonists for inflammatory, immune and cardiovascular disorders

July 23, 1999

Licensing opportunity from NIH: broad-spectrum chemokine antagonist

July 22, 1999

Amgen reveals latest in inhibitors of matrix metalloproteinases

July 21, 1999

New Amgen compounds for disorders mediated by TNF-alpha, collagenase and/or stromelysin

July 20, 1999

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

July 19, 1999

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.